+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Anthrax Treatment - Global Strategic Business Report - Product Thumbnail Image

Anthrax Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 373 Pages
  • Global
From
Hyoscine - Global Strategic Business Report - Product Thumbnail Image

Hyoscine - Global Strategic Business Report

  • Report
  • August 2025
  • 281 Pages
  • Global
From
Tourette Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Tourette Syndrome Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
Topical Drugs CDMO - Global Strategic Business Report - Product Thumbnail Image

Topical Drugs CDMO - Global Strategic Business Report

  • Report
  • August 2025
  • 370 Pages
  • Global
From
Dermatology Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatology Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 372 Pages
  • Global
From
From
Male Urinary Incontinence - Global Strategic Business Report - Product Thumbnail Image

Male Urinary Incontinence - Global Strategic Business Report

  • Report
  • August 2025
  • 563 Pages
  • Global
From
Loratadine - Global Strategic Business Report - Product Thumbnail Image

Loratadine - Global Strategic Business Report

  • Report
  • August 2025
  • 373 Pages
  • Global
From
Cannabidiol (CBD) Pet - Global Strategic Business Report - Product Thumbnail Image

Cannabidiol (CBD) Pet - Global Strategic Business Report

  • Report
  • August 2025
  • 383 Pages
  • Global
From
Acitretin - Global Strategic Business Report - Product Thumbnail Image

Acitretin - Global Strategic Business Report

  • Report
  • August 2025
  • 470 Pages
  • Global
From
Psyllium - Global Strategic Business Report - Product Thumbnail Image

Psyllium - Global Strategic Business Report

  • Report
  • August 2025
  • 383 Pages
  • Global
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 480 Pages
  • Global
From
Caspofungin - Global Strategic Business Report - Product Thumbnail Image

Caspofungin - Global Strategic Business Report

  • Report
  • August 2025
  • 279 Pages
  • Global
From
Anterior Uveitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Anterior Uveitis Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 383 Pages
  • Global
From
Cannabis Pharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Cannabis Pharmaceuticals - Global Strategic Business Report

  • Report
  • August 2025
  • 116 Pages
  • Global
From
From
Erectile Dysfunction Drugs - Global Strategic Business Report - Product Thumbnail Image

Erectile Dysfunction Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 287 Pages
  • Global
From
Connective Tissue Diseases - Global Strategic Business Report - Product Thumbnail Image

Connective Tissue Diseases - Global Strategic Business Report

  • Report
  • August 2025
  • 385 Pages
  • Global
From
Neurology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Neurology Clinical Trials - Global Strategic Business Report

  • Report
  • August 2025
  • 385 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more